Heart Stiffness in Amyloidosis: A Study Using MRI
Part of Hormones & metabolism clinical trials.
This study uses a special MRI scan to measure how stiff the heart muscle is in people with cardiac amyloidosis. The goal is to better understand the condition and potentially guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years or older.
- You have been diagnosed with either ATTR or AL cardiac amyloidosis within the past 10 years.
- You have not been in the hospital for a heart problem in the last 2 weeks.
- You can lie flat on your back for 30 minutes and hold your breath for 10 seconds.
- You do not have a pacemaker, defibrillator, or other metal implant that would make MRI unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a new type of heart scan (MCG) to help understand cardiac amyloidosis. It may help doctors learn more about the condition without needing invasive tests.
This study aims to find, describe, and track people with cardiac amyloidosis over time. It uses MRI scans and other tests to better understand the condition, which may help guide future treatment.
This study tests different heart scans to find heart amyloidosis, a condition where abnormal proteins build up in the heart, in people who have certain warning signs. The goal is to see which test works best to help diagnose it faster.
This study looks at how a type of heart condition called transthyretin cardiac amyloidosis changes over time, using a special imaging test called a bone scan. The goal is to see if the scan can help track the disease and potentially improve care.
This study uses a hybrid PET/MRI scanner to take detailed images of the heart in people with amyloidosis. The goal is to see how well this scan shows the buildup of amyloid protein, which could help doctors better diagnose and manage the condition.
This research study checks a small sample of heart tissue during pacemaker or defibrillator placement to see if amyloidosis, a condition where abnormal proteins build up in organs, is present. It aims to find amyloidosis earlier so treatment can start sooner.
Hear when a new Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.